Patents/Assignees

Marinus Pharmaceuticals, Inc.

6 patents in portfolio

US12268696utility2025
Ganaxolone for Use in Treating Tuberous Sclerosis Complex and Seizure Disorders
0 cites
US12246026utility2025
Ganaxolone for Use in Treatment of Status Epilepticus
0 cites
US12115169utility2024
Ganaxolone for Use in Treating Tuberous Sclerosis Complex and Seizure Disorders
0 cites
US11980625utility2024
Ganaxolone for Use in Treating Tuberous Sclerosis Complex
0 cites
US11701367utility2023
Ganaxolone for Use in Treating Tuberous Sclerosis Complex
0 cites
US11679117utility2023
Ganaxolone for Use in Treatment of Status Epilepticus
0 cites